We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Sloning Biotechnology and Microsynth Announce Exclusive Distribution Partnership for Switzerland

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Sloning Biotechnology and Microsynth Announce Exclusive Distribution Partnership for Switzerland"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Sloning Biotechnology has announced a distribution partnership with Microsynth, a provider of custom oligonucleotide synthesis and DNA sequencing to the Swiss market.

Microsynth will exclusively market and sell Sloning's gene synthesis service (Slonomics™) and the product family of mutant libraries (Slonomax™) in Switzerland.

“We are very pleased that Microsynth will join our global network of qualified distributors. With its strong technological expertise, market position and service philosophy Microsynth is the ideal partner for Sloning to develop the Swiss market,” stated Thomas Matthes, the company CBO.

Dr. Tobias Schmidheini, founder and CEO of Microsynth said, “Sloning´s products and services perfectly complement our portfolio. It’s a strategic development for our organization. We are looking forward to offering Sloning´s products to our customer base.”